Top 50 UK Pharmaceutical & Biotech Companies Websites 2025
Thursday 29th May 2025
The following information has been compiled through a detailed review of the homepage designs of the leading UK pharmaceutical and biotech companies, based on website screenshots taken in April 2025. This research aims to highlight current digital trends, design styles and content strategies used across the sector’s most prominent online platforms.
The list of companies is based on 2024 revenue data, sourced from a range of industry publications and databases. For clarity and ease of comparison, the table has been split by the location of each company’s headquarters and their primary therapeutic or research focus.
Please note that this is a research-based piece. The websites featured in this analysis were not necessarily designed or developed by Tela. All homepage screenshots were captured in April 2025.
Top UK Pharmaceutical & Biotech Companies by 2024 Revenue
The following table of the top UK pharmaceutical and biotech companies by revenue in 2024 has been compiled from a range of industry sources. These include: Fierce Pharma, Global Database, Beauhurst, PharmiWeb.com, PharmExec, Drug Discovery Trends, GetReskilled, IoT World Magazine, Citeline and ABPI.
Together, these references provide a comprehensive view of the UK’s leading pharmaceutical and biotech firms, combining global market performance with domestic insights and financial data.
| Rank | Company Name | 2024 Revenue (Approx.) | Headquarters | Focus Areas |
| 1 | AstraZeneca plc | $54.1B (~£43.3B) | Cambridge | Oncology, cardiovascular, respiratory, immunology |
| 2 | GSK plc (GlaxoSmithKline) | £31.4B | London | Vaccines, HIV, oncology, specialty medicines |
| 3 | Haleon plc | £11.2B | Weybridge | Consumer healthcare (Sensodyne, Panadol, Centrum) |
| 4 | Hikma Pharmaceuticals plc | $3.16B (~£2.5B) | London | Generics, injectables, branded pharmaceuticals |
| 5 | Indivior plc | $1.0B (~£0.8B) | Slough | Addiction treatment (opioid dependence) |
| 6 | Dechra Pharmaceuticals plc | £0.8B | Northwich | Veterinary pharmaceuticals |
| 7 | Vectura Group plc | £0.5B | Chippenham | Inhalation therapies, drug delivery systems |
| 8 | Oxford Biomedica plc | £0.4B | Oxford | Gene and cell therapy, lentiviral vector development |
| 9 | Alliance Pharma plc | £0.3B | Chippenham | Niche pharmaceutical and healthcare products |
| 10 | Clinigen Group plc | £0.3B | Burton upon Trent | Unlicensed medicines, clinical trial supply |
| 11 | GW Pharmaceuticals (Jazz) | £0.3B | Cambridge | Cannabinoid-based therapies |
| 12 | Ergomed plc | £0.2B | Guildford | Clinical research, pharmacovigilance |
| 13 | Shield Therapeutics plc | £0.1B | Gateshead | Iron deficiency therapies |
| 14 | Verona Pharma plc | £0.1B | London | Respiratory diseases (COPD) |
| 15 | Circassia Group plc | £0.1B | Oxford | Respiratory diagnostics and therapies |
| 16 | Synairgen plc | £0.05B | Southampton | Respiratory antiviral therapies |
| 17 | Futura Medical plc | £0.05B | Guildford | Sexual health, pain relief products |
| 18 | Summit Therapeutics plc | £0.05B | Oxford | Antibiotic and genetic disease therapies |
| 19 | Silence Therapeutics plc | £0.05B | London | RNA interference (RNAi) therapeutics |
| 20 | Redx Pharma plc | £0.04B | Alderley Park | Oncology and fibrosis therapies |
| 21 | Oxford Nanopore Technologies | £0.04B | Oxford | DNA/RNA sequencing technologies |
| 22 | Abcam plc | £0.03B | Cambridge | Research antibodies and reagents |
| 23 | BTG plc (Boston Scientific) | £0.03B | London | Interventional medicine, oncology |
| 24 | Genus plc | £0.03B | Basingstoke | Animal genetics, biotechnology |
| 25 | Allergy Therapeutics plc | £0.02B | Worthing | Allergy vaccines and immunotherapy |
| 26 | Advanced Medical Solutions | £0.02B | Winsford | Surgical and wound care products |
| 27 | Consort Medical plc | £0.02B | Hemel Hempstead | Drug delivery devices |
| 28 | Bioventix plc | £0.02B | Farnham | Antibody development for diagnostics |
| 29 | Cambridge Cognition Holdings | £0.01B | Cambridge | Cognitive assessment software |
| 30 | Angle plc | £0.01B | Guildford | Liquid biopsy and cancer diagnostics |
| 31 | Destiny Pharma plc | £0.01B | Brighton | Anti-infective drug development |
| 32 | e-Therapeutics plc | £0.01B | Oxford | Computational drug discovery |
| 33 | Evgen Pharma plc | £0.01B | Alderley Park | Oncology and neurological disease therapies |
| 34 | Fusion Antibodies plc | £0.01B | Belfast | Antibody engineering and production |
| 35 | Genedrive plc | £0.01B | Manchester | Molecular diagnostics |
| 36 | MaxCyte Inc. | £0.01B | London | Cell engineering and therapy |
| 37 | Mereo BioPharma Group plc | £0.01B | London | Rare diseases and oncology |
| 38 | OptiBiotix Health plc | £0.01B | York | Microbiome modulation for health |
| 39 | Oxford BioDynamics plc | £0.01B | Oxford | Epigenetic biomarkers |
| 40 | Physiomics plc | £0.01B | Oxford | Oncology modeling and simulation |
| 41 | Renalytix plc | £0.01B | London | Kidney diagnostics and AI |
| 42 | Sareum Holdings plc | £0.01B | Cambridge | Kinase inhibitors for cancer and autoimmune diseases |
| 43 | Scancell Holdings plc | £0.01B | Nottingham | Cancer immunotherapies |
| 44 | Syncona Ltd | £0.01B | London | Life science investment company |
| 45 | Tiziana Life Sciences plc | £0.01B | London | Immunology and oncology therapies |
| 46 | ValiRx plc | £0.01B | London | Cancer therapeutics development |
| 47 | Venture Life Group plc | £0.01B | Bracknell | |
| 48 | Arecor Therapeutics plc | |||
| 49 | Poolbeg Pharma plc |
AstraZeneca plc
AstraZeneca’s homepage features a clean and professional design with a focus on scientific innovation. The layout is straightforward, with a top navigation bar providing easy access to key sections such as Research & Development, Products and Sustainability. High-quality imagery and concise text highlight the company’s commitment to advancing healthcare.
GSK plc (GlaxoSmithKline)
GSK’s website showcases a modern and dynamic design, reflecting its focus on biopharma innovation. The homepage employs bold visuals and a vibrant colour palette, with intuitive navigation that guides users to information about the company’s purpose, strategy and specialist areas.
Haleon plc
Haleon’s homepage presents a minimalist and user-friendly interface, emphasising its mission to deliver better everyday health. The design utilises a restrained colour scheme with accents of their vibrant green branding and features clear calls to action that direct visitors to learn more about the company’s products and initiatives.
Hikma Pharmaceuticals plc
Hikma’s website offers a straightforward and approachable design, with a focus on accessibility and clarity. The homepage highlights the company’s global presence and commitment to quality medicines, using a simple layout and a warm colour palette to convey trust and reliability.
Indivior plc
Indivior’s homepage is designed to be informative and engaging, featuring sections on the latest news, financial results and career opportunities. The layout is clean, with prominent visuals and easy navigation that reflect the company’s dedication.
Dechra Pharmaceuticals plc
Dechra’s website emphasises its specialisation in veterinary pharmaceuticals through a clean and professional design. The homepage features clear messaging about the company’s purpose and expertise, with intuitive navigation directing users to product information, news and sustainability efforts.
Vectura Group plc
Vectura’s homepage focuses on its role in inhaled drug development, presenting a sleek and modern design. The site offers easy access to information about the company’s services and expertise, with a layout that balances text and imagery to effectively communicate its capabilities.
Oxford Biomedica plc
Oxford Biomedica’s website showcases its leadership in gene and cell therapy through a visually appealing and informative homepage. The design features high-quality images and concise text that highlight the company’s services, experience and commitment to innovation.
Alliance Pharma plc
Alliance Pharma’s homepage presents a welcoming and collaborative image, with a design that emphasises partnerships and brand development. The layout is clean and organised, featuring sections that guide users to information about the company’s business model, strategy and product portfolio.
Clinigen Group plc
Clinigen’s website features a professional and informative design, focusing on its services in providing access to medicines and clinical trial support. The homepage offers clear navigation to various service areas, with a layout that balances detailed information and visual elements to engage visitors.
GW Pharmaceuticals (Jazz)
GW Pharmaceuticals, now integrated into Jazz Pharmaceuticals, maintains a professional and informative homepage. The design emphasises their commitment to improving patients’ lives by identifying and developing products that address unmet medical needs. The layout is user-friendly, with clear navigation to sections such as ‘Our Medicines’ and ‘Clinical Trials’, reflecting their focus on biopharmaceutical innovation.
Ergomed plc
Ergomed’s homepage presents a clean and professional design, highlighting their global footprint in clinical research. The site features straightforward navigation, directing users to information about their services in oncology and rare disease clinical trials. The use of concise text and imagery underscores their expertise in managing complex clinical projects.
Shield Therapeutics plc
Shield Therapeutics’ homepage adopts a patient-focused design, emphasising their mission to improve the lives of individuals suffering from iron deficiency. The layout is straightforward, with easy access to sections for patients, healthcare professionals and investors. The use of warm colors and clear messaging reflects their commitment to addressing unmet medical needs.
Verona Pharma plc
Verona Pharma’s homepage features a modern and visually engaging design, focusing on their development of novel treatments for chronic respiratory diseases. The site employs high-quality imagery and concise text to communicate their scientific approach. Navigation is intuitive, guiding users to information about their pipeline and corporate updates.
Circassia Group plc
Circassia, now operating as NIOX Group, presents a homepage centered on their expertise in respiratory diagnostics. The design is clean and professional, with a focus on their FeNO testing products for asthma management. Navigation is straightforward, providing easy access to product information and investor relations.
Synairgen plc
Synairgen’s homepage is designed to convey their focus on developing treatments for severe viral lung infections. The layout is simple and informative, with sections highlighting their lead candidate, SNG001. The use of clear headings and concise descriptions facilitates user understanding of their research endeavors. Additionally, the website emphasises podcasts, to engage visitors and provide further insight into the company’s scientific progress and thought leadership in respiratory care.
Futura Medical plc
Futura Medical’s homepage showcases a sleek and modern design, reflecting their innovation in sexual health and pain relief products. The site features bold visuals and succinct text, with intuitive navigation directing users to investor information and product pipelines.
Summit Therapeutics plc
Summit Therapeutics’ homepage presents a professional and informative design, emphasising their commitment to optimising human health through biopharmaceutical oncology. The layout is clean with clear navigation to sections on their pipeline, company information and investor relations.
Silence Therapeutics plc
Silence Therapeutics’ homepage presents a clean and professional design, emphasising their cutting-edge work in RNA interference (RNAi) therapies. The design is sleek, with a focus on clear, concise messaging about their technology and pipeline. The site is user-friendly with sections highlighting their scientific approach, drug development stages and clinical trials. This allows visitors to quickly learn about their innovations in gene silencing. The homepage is visually modern and provides easy navigation to investor relations and research updates.
Redx Pharma plc
Redx Pharma’s homepage features a dynamic and scientific design that highlights their focus on developing drugs for cancer and other serious diseases. The site uses high-quality imagery and bold colors to showcase their expertise in drug discovery and development. Navigation is straightforward, providing access to their research, therapeutic areas and ongoing clinical trials. The site’s clean layout and clear content convey Redx Pharma’s commitment to transforming the treatment landscape for patients in need.
Oxford Nanopore Technologies
Oxford Nanopore Technologies’ homepage has a visually striking design, featuring bold graphics and interactive elements that reflect their focus on cutting-edge DNA sequencing technology. The layout is clean, with a well-organised structure allowing users to explore their innovative solutions for real-time molecular analysis. The homepage includes clear calls to action, leading visitors to product information, applications and research collaborations. Their engaging design mirrors their role in revolutionising genomic research and diagnostics.
Abcam plc
Abcam’s homepage is characterised by a bright and accessible design, centered around their role as a leading supplier of protein research tools. The site features clear, concise sections that showcase their product offerings, including antibodies and reagents. Their homepage includes engaging visuals and interactive content that directs users to product categories, services and research resources. Navigation is intuitive and the use of visuals highlights Abcam’s dedication to empowering scientific research.
BTG plc (a part of Boston Scientific)
BTG’s homepage, now part of Boston Scientific, showcases a professional design with a focus on their medical device and pharmaceutical products. The site uses a clean, structured layout to emphasise their work in interventional medicine. Key areas such as product information, clinical solutions and research capabilities are highlighted and the navigation provides quick access to investor relations and company updates. The homepage reflects BTG’s commitment to improving patient outcomes through innovative technologies.
Genus plc
Genus’ homepage features a simple and clean design, with a strong emphasis on their animal genetics business. The site uses an easy-to-navigate structure that highlights their expertise in improving animal breeding for agricultural and pharmaceutical applications. Clear messaging emphasises their commitment to sustainable farming practices and animal health, while the homepage’s layout ensures that users can quickly access information about their services, products and global impact.
Allergy Therapeutics plc
Allergy Therapeutics’ homepage is designed to highlight their focus on developing immunotherapies for allergic diseases. The site employs a simple yet effective layout, with sections that provide detailed information on their research and product pipeline. The homepage uses a combination of visuals and concise text to communicate their dedication to improving patient lives through innovative allergy treatments. Navigation is intuitive, with easy access to company news and clinical trial updates.
Advanced Medical Solutions Group plc
Advanced Medical Solutions’ homepage has a professional design that emphasises their expertise in wound care and surgical products. The website features a clean, structured layout with prominent sections on their product offerings, clinical applications and research initiatives. Key areas of focus are presented clearly, allowing users to explore the company’s broad range of advanced medical solutions for wound management. Navigation is straightforward, ensuring easy access to product catalogs and business updates.
Consort Medical plc
Website’s down
Bioventix plc
Bioventix’ homepage presents a clean, professional design with a focus on their specialty in monoclonal antibodies. The site features clear sections highlighting their antibody production and diagnostic services. The layout is straightforward, with easy-to-understand descriptions of their products and research capabilities. The homepage’s simple navigation ensures that visitors can quickly access key information about their offerings and recent updates.
Cambridge Cognition Holdings plc
Cambridge Cognition’s homepage has a polished design that reflects their focus on cognitive assessment software and digital health solutions. The site features clear navigation, with sections dedicated to their technology, product offerings and client services. The homepage’s layout is designed to engage users with a combination of visuals and concise messaging, emphasising the company’s role in enhancing cognitive health through innovative technologies.
Angle plc
Angle’s homepage is clean and scientific, focusing on their revolutionary liquid biopsy technology for cancer detection. The design is minimalistic, with sections dedicated to their product pipeline, technology and clinical applications. The site features clear headings and concise content that quickly convey their innovative approach to precision medicine, with easy navigation to key areas such as news, investor relations and scientific updates.
Destiny Pharma plc
Destiny Pharma’s homepage presents a modern design focused on their work in developing anti-infectives. The site uses clear headings and informative text to guide users through their product offerings and clinical trials. The homepage is structured to highlight the company’s commitment to tackling antibiotic resistance and the simple layout makes it easy for users to explore key areas of the website.
e-Therapeutics plc
e-Therapeutics’ homepage showcases a clean and professional design with a focus on their drug discovery platform and computational biology expertise. The site features a simple layout, with sections that explain their research approach and product development processes. The homepage emphasises their innovative use of technology in the drug discovery process and the design ensures users can easily find detailed information on their projects and collaborations.
Evgen Pharma plc (Rebranded to TheraCryf)
Evgen Pharma’s homepage highlights their focus on developing drugs for cancer and neurological conditions. The design is sleek and simple, with sections that emphasise their lead drug candidate and clinical pipeline. Navigation is straightforward, allowing users to explore information about the company’s research, clinical trials and investor relations. The homepage effectively communicates their commitment to delivering treatments for unmet medical needs.
Fusion Antibodies plc
Fusion Antibodies’ homepage focuses on their specialisation in providing custom antibody solutions. The design is clean and professional, with sections dedicated to their services in antibody discovery and development. Clear navigation allows users to easily access information about their technology platform, product offerings and case studies. The site’s layout emphasises their expertise in the biopharmaceutical industry.
Genedrive plc
Genedrive’s homepage has a sleek design with a focus on their molecular diagnostics solutions. The site features a user-friendly layout with sections that highlight their diagnostic products and applications. The homepage’s structure ensures that visitors can easily navigate to key information about their genetic testing solutions, particularly in infectious diseases and antibiotic resistance.
MaxCyte Inc.
MaxCyte’s homepage is designed to showcase their innovative cell engineering platform. The site uses high-quality visuals and a clean, structured layout to highlight their technologies for cell-based therapies and drug discovery. Navigation is intuitive, guiding users to learn more about the company’s capabilities, research initiatives and partnerships.
Mereo BioPharma Group plc
Mereo BioPharma’s homepage features a straightforward design that emphasises their rare disease treatments and drug development pipeline. The layout is simple, with sections focused on their research, clinical trials and product portfolio. The homepage effectively conveys the company’s mission to improve the lives of patients with underserved diseases.
OptiBiotix Health plc
OptiBiotix Health’s homepage emphasises their innovative work in the microbiome and gut health sector. The site features a modern design with clear navigation to key areas such as their product portfolio, scientific research and partnerships. The homepage highlights their commitment to developing products that improve human health through microbiome modulation.
Oxford BioDynamics plc
Oxford BioDynamics’ homepage presents a clean and professional design, focusing on their work in epigenetics and biomarker discovery. The site uses a simple layout with sections highlighting their technologies and applications in drug discovery and diagnostics. The homepage emphasises their scientific expertise and commitment to advancing personalised medicine.
Physiomics plc
Physiomics’ homepage features a minimalistic design focused on their computational modeling services for drug discovery. The site offers clear sections that explain their services in systems biology and pharmacokinetics. Navigation is easy, allowing users to explore their approach to modeling disease mechanisms and treatment responses.
Renalytix plc
Renalytix’s homepage showcases their focus on AI-powered diagnostics for kidney disease. The design is modern and clean, with clear sections that highlight their flagship product and the role of artificial intelligence in improving kidney disease diagnosis. The homepage’s layout emphasises their mission to improve patient outcomes through innovative diagnostics.
Sareum Holdings plc
Sareum Holdings’ homepage features a clean and simple design, with a focus on their drug discovery pipeline and preclinical research. The layout is easy to navigate, with sections dedicated to their drug candidates and the company’s scientific approach. The homepage effectively communicates Sareum’s focus on oncology and autoimmune diseases.
Scancell Holdings plc
Scancell’s homepage focuses on their work in cancer immunotherapy. The design is modern and informative, with sections that highlight their cancer vaccine pipeline and clinical trials. Navigation is intuitive, providing access to key areas such as scientific research, news and investor relations.
Syncona Ltd
Syncona’s homepage has a clean and professional design, emphasising their focus on developing breakthrough therapies for life-threatening diseases. The site provides clear access to their portfolio companies and investments in biotech. The homepage is structured to highlight their role as a leading healthcare investor and their commitment to advancing novel treatments.
Tiziana Life Sciences plc
Tiziana Life Sciences’ homepage features a simple yet effective design focused on their work in immuno-oncology and inflammatory diseases. The site highlights their clinical pipeline and the company’s commitment to developing targeted therapies. Navigation is straightforward, allowing visitors to access detailed information on their ongoing research.
ValiRx plc
ValiRx’s homepage is designed to highlight their work in cancer and women’s health. The site features a modern, clean design with sections dedicated to their drug development pipeline and clinical trial updates. The homepage is structured to provide visitors with an understanding of the company’s mission and research focus.
Venture Life Group plc
Venture Life Group’s homepage emphasises their expertise in developing and marketing self-care products for various health conditions. The design is clean and user-friendly, with sections highlighting their product offerings and research. Navigation is intuitive and the homepage effectively communicates the company’s commitment to providing accessible healthcare solutions.
Arecor Therapeutics plc
Arecor Therapeutics’ homepage features a professional design with a focus on their innovative work in biologic drug formulations. The site emphasises their platform technology and the impact it has on improving the efficacy and stability of therapeutic proteins. The homepage’s clean layout and clear navigation reflect Arecor’s commitment to advancing biopharmaceutical science.
Poolbeg Pharma plc
Poolbeg Pharma’s homepage highlights their focus on infectious disease treatments and vaccine development. The design is modern and clear, with sections dedicated to their research pipeline, clinical trials and the company’s approach to solving global health challenges. The homepage is structured to facilitate easy navigation and quick access to relevant information.